Head-to-head comparison of multi-dose oritavancin and dalbavancin for complicated infections: A propensity score-matched analysis.

MLA

Steuber, Taylor D., et al. “Head-to-Head Comparison of Multi-Dose Oritavancin and Dalbavancin for Complicated Infections: A Propensity Score-Matched Analysis.” International Journal of Antimicrobial Agents, vol. 63, no. 6, June 2024, p. 107165. EBSCOhost, https://doi.org/10.1016/j.ijantimicag.2024.107165.

APA

Steuber, T. D., Gipson, H., Boyett, B., Belk, M., Thayer, B., & Edwards, J. (2024). Head-to-head comparison of multi-dose oritavancin and dalbavancin for complicated infections: A propensity score-matched analysis. International Journal of Antimicrobial Agents, 63(6), 107165. https://doi.org/10.1016/j.ijantimicag.2024.107165

Chicago

Steuber, Taylor D, Hannah Gipson, Brian Boyett, Madeline Belk, Blain Thayer, and Jonathan Edwards. 2024. “Head-to-Head Comparison of Multi-Dose Oritavancin and Dalbavancin for Complicated Infections: A Propensity Score-Matched Analysis.” International Journal of Antimicrobial Agents 63 (6): 107165. doi:10.1016/j.ijantimicag.2024.107165.